+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Crotamiton Market by Formulation, Application, Distribution Channel, End User, Packaging - Global Forecast to 2030- Product Image
Crotamiton Market by Formulation, Application, Distribution Channel, End User, Packaging - Global Forecast to 2030- Product Image
Sale

Crotamiton Market by Formulation, Application, Distribution Channel, End User, Packaging - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082682
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Crotamiton Market grew from USD 135.35 million in 2024 to USD 141.64 million in 2025. It is expected to continue growing at a CAGR of 4.51%, reaching USD 176.43 million by 2030.

Understanding Crotamiton’s Evolving Role in Dermatological Care

Crotamiton has emerged as a cornerstone in dermatological care, combining anti-inflammatory and antipruritic properties to address a spectrum of skin conditions. Initially developed to alleviate itching and discomfort in eczema and psoriasis patients, its molecular profile also delivers therapeutic relief for scabies infestations. As topical treatments continue to gain preference over systemic therapies, Crotamiton’s gentle efficacy has solidified its reputation among healthcare professionals and patients alike.

The contemporary skincare landscape demands formulations that balance potency with tolerability. In this context, Crotamiton stands out for its versatility: available in creams, gels, and lotions, it adapts to diverse patient needs and skin types. Progressive formulations have improved absorption rates and minimized residue, enhancing patient compliance. As healthcare providers increasingly prioritize evidence-based protocols, Crotamiton’s robust clinical track record positions it as a go-to option in both dermatology clinics and home care settings.

Emerging Trends Reshaping the Crotamiton Market Landscape

The Crotamiton market is experiencing transformative shifts driven by regulatory realignments, patient empowerment, and digital innovation. Revised guidelines on topical agent safety have prompted manufacturers to reformulate existing products, ensuring minimal systemic absorption and reduced irritation potential. Concurrently, expanded direct-to-consumer channels have heightened patient awareness, fueling demand for transparent labeling and clinically validated efficacy.

In tandem, telemedicine adoption has redefined prescription pathways, enabling remote diagnosis and prescription of Crotamiton treatments. This digital acceleration has compelled stakeholders across the value chain to optimize supply networks and bolster online retail platforms. Furthermore, collaborative research initiatives are exploring novel synergistic combinations, setting the stage for next-generation formulations that could broaden Crotamiton’s therapeutic scope beyond pruritus and scabies management.

Assessing the 2025 United States Tariff Surge on Crotamiton Trade

The United States’ 2025 tariff adjustments have introduced new cost considerations for Crotamiton importers and domestic producers. Increased duties on key active pharmaceutical ingredients have elevated production expenses, prompting formulators to explore alternative sourcing strategies. As a result, some manufacturers are accelerating local partnerships or investing in backward integration to secure raw material supply and mitigate price volatility.

These shifts in cost structure are cascading through distribution channels. Clinics and hospital pharmacies are revisiting procurement contracts, while third-party online platforms and manufacturer websites are recalibrating price points to maintain competitive appeal. Ultimately, these tariff-driven dynamics underscore the importance of agile supply chain management and strategic procurement planning in sustaining market access and preserving margin profiles under evolving trade policies.

Decoding Key Segmentation Dynamics Driving Crotamiton Adoption

A nuanced segmentation analysis reveals the intricate drivers propelling Crotamiton consumption. Formulation preferences vary from topical creams favored for their emollient texture to gels preferred for rapid absorption, while lotions offer a balance that appeals to patients with sensitive skin. Application areas bifurcate into antipruritic usage-where relief from chronic itching dominates clinical protocols-and scabies treatment, which demands precise dosing regimens to eradicate mites effectively.

Distribution pathways span traditional clinic settings to hospital pharmacies, yet online retail is rapidly gaining traction via manufacturer websites and third-party platforms, offering convenience and confidentiality. Concurrently, chain and independent pharmacies continue to serve as trusted access points for repeat prescriptions. On the end-user front, dermatology clinics set clinical benchmarks, hospitals handle acute cases, and home care scenarios range from caregiver administration to self-application. Packaging formats in bottles, jars, and tubes further influence user experience, with each container tailored to specific compliance and storage requirements.

Regional Performance Snapshots Highlighting Crotamiton Trajectories

Geographical dynamics significantly influence the uptake and performance of Crotamiton products. In the Americas, established regulatory frameworks and high consumer awareness sustain robust demand, while new reimbursement models are shaping formulary access in both public and private sectors. Conversely, in Europe, Middle East & Africa, heterogeneous regulatory landscapes and evolving healthcare infrastructures create pockets of accelerated growth alongside regions where market penetration remains nascent.

The Asia-Pacific region registers the most pronounced growth trajectory, driven by burgeoning healthcare investment, rising skin disease prevalence, and expanding retail networks. Local market entrants are leveraging partnerships with global players to fast-track product registrations and streamline distribution. Taken together, these regional nuances underscore the necessity of tailored go-to-market strategies that align with specific regulatory, economic, and cultural contexts.

Competitive Landscape and Leading Players in Crotamiton Markets

The competitive arena for Crotamiton features well-established dermatology specialists alongside agile innovators. Leading pharmaceutical manufacturers continue to invest in advanced formulation technologies, securing patents that reinforce market exclusivity. Simultaneously, emerging biotech firms are exploring novel Crotamiton derivatives and combination therapies that could redefine treatment paradigms for pruritic and parasitic skin disorders.

Strategic alliances and licensing agreements have become pivotal in accelerating market entry and expanding product portfolios. Key players leverage global distribution networks to enhance market penetration, while niche competitors focus on differentiated branding and targeted patient education campaigns. As intellectual property timelines evolve, companies are diversifying through adjacent dermatological compounds and digital health service integrations to safeguard future growth.

Strategic Imperatives for Stakeholders in the Crotamiton Sector

Industry leaders should prioritize formulation innovation to address the dual imperatives of efficacy and patient convenience. Investing in research to optimize skin absorption and minimize potential irritation will strengthen product positioning. At the same time, diversifying supply chains through regional manufacturing partnerships or backward integration can safeguard against tariff-induced cost pressures.

Enhancing digital engagement through telehealth collaborations and user-friendly online platforms will capture the preferences of an increasingly connected patient base. Additionally, targeted medical education programs for clinicians and caregivers can drive adoption in both clinical and home care environments. By aligning distribution strategies with segmentation insights-from cream users seeking emollient applications to hospitals managing scabies outbreaks-stakeholders can unlock new revenue streams while reinforcing brand loyalty.

Rigorous Approach Underpinning the Crotamiton Market Analysis

This analysis hinges on a rigorous, multi-tiered research framework. Secondary intelligence was gathered from authoritative regulatory filings, peer-reviewed journals, and industry white papers to establish a foundational understanding of Crotamiton’s clinical and commercial profile. Primary insights were secured through in-depth interviews with dermatologists, distribution partners, and key opinion leaders to validate market realities and emerging trends.

A structured segmentation methodology was applied to distill the market into distinct formulation, application, distribution, end-user, and packaging categories. Regional analyses were informed by localized data on healthcare spending, reimbursement policies, and patient demographics. Finally, expert validation workshops consolidated findings, ensuring accuracy, relevance, and actionability for decision-makers across the dermatological landscape.

Concluding Perspectives on Crotamiton’s Path Forward

Crotamiton’s evolution reflects the broader trajectory of dermatological therapeutics: a relentless pursuit of safe, effective, and patient-centric solutions. The confluence of regulatory shifts, digital transformation, and supply chain realignments presents both challenges and opportunities. Stakeholders who harness segmentation and regional insights will be best positioned to navigate tariff headwinds and leverage emerging channels.

As competitive dynamics intensify and new clinical data emerge, maintaining a proactive posture will be essential. Companies that foster collaborative innovation, optimize distribution networks, and engage stakeholders across the continuum of care will define the next chapter in Crotamiton’s market story. In doing so, they will ensure that patients worldwide continue to benefit from its proven therapeutic efficacy.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Formulation
    • Cream
    • Gel
    • Lotion
  • Application
    • Antipruritic
    • Scabies Treatment
  • Distribution Channel
    • Clinic
    • Hospital Pharmacy
    • Online Retail
      • Manufacturer Website
      • Third-Party Platform
    • Pharmacy
      • Chain Pharmacy
      • Independent Pharmacy
  • End User
    • Dermatology Clinics
    • Home Care
      • Caregiver Administration
      • Self-Administration
    • Hospitals
  • Packaging
    • Bottle
    • Jar
    • Tube
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Galderma S.A.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Laboratoires Gilbert
  • Riemser Pharma GmbH

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Crotamiton Market, by Application
8.1. Introduction
8.2. Allergy Relief
8.2.1. Itch Suppression
8.2.2. Symptom Alleviation
8.3. Dermatology
8.3.1. Eczema Management
8.3.2. Psoriasis Control
8.4. Insect Bites
8.4.1. Pain Relief
8.4.2. Swelling Reduction
8.5. Scabies Treatment
8.5.1. Contagion Control
8.5.2. Symptom Suppression
9. Crotamiton Market, by Form
9.1. Introduction
9.2. Cream
9.2.1. Medicated Cream
9.2.2. Regular Cream
9.3. Gel
9.3.1. Cooling Gel
9.3.2. Regular Gel
9.4. Lotion
9.4.1. Dry Skin Lotion
9.4.2. Oily Skin Lotion
10. Crotamiton Market, by End-user
10.1. Introduction
10.2. Clinics
10.2.1. Dermatology Clinics
10.2.2. Private Clinics
10.3. Home Care
10.3.1. Over-the-counter
10.3.2. Self-prescription
10.4. Hospitals
10.4.1. Inpatient Care
10.4.2. Outpatient Care
11. Crotamiton Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Bulk Orders
11.2.2. Direct Purchase
11.3. Online Pharmacies
11.3.1. E-commerce Platforms
11.3.2. Manufacturer Websites
11.4. Retail Pharmacies
11.4.1. Chain Stores
11.4.2. Independent Pharmacies
12. Crotamiton Market, by Treatment Phase
12.1. Introduction
12.2. Initial Treatment
12.2.1. First-line Therapy
12.2.2. Preventive Measures
12.3. Maintenance Therapy
12.3.1. Long-term Use
12.3.2. Periodic Application
12.4. Post-Treatment
12.4.1. Complimentary Care
12.4.2. Recovery Regimen
13. Crotamiton Market, by Patient Demographics
13.1. Introduction
13.2. Adults
13.2.1. Aged 18-34
13.2.2. Aged 35-50
13.2.3. Aged 51 and Above
13.3. Children
13.3.1. Infants
13.3.2. School-age
13.3.3. Toddlers
13.4. Geriatric Population
13.4.1. Aged 60-75
13.4.2. Aged 76 and Above
14. Americas Crotamiton Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Crotamiton Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Crotamiton Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. A.S. Lifesciences
17.3.2. Abbott Laboratories
17.3.3. Adooq Bioscience LLC
17.3.4. Catapharma Chemicals Pvt. Ltd.
17.3.5. Connote Healthcare
17.3.6. Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
17.3.7. Incepta Pharmaceuticals Ltd.
17.3.8. Merck KGaA
17.3.9. Senova Technology Co., Ltd.
17.3.10. SimSon Pharma Limited
17.3.11. Taj Pharmaceuticals Limited
17.3.12. Zuche Pharmaceutical
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CROTAMITON MARKET MULTI-CURRENCY
FIGURE 2. CROTAMITON MARKET MULTI-LANGUAGE
FIGURE 3. CROTAMITON MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CROTAMITON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CROTAMITON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CROTAMITON MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CROTAMITON MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CROTAMITON MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CROTAMITON MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CROTAMITON MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CROTAMITON MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CROTAMITON MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CROTAMITON MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CROTAMITON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CROTAMITON MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CROTAMITON MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CROTAMITON MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CROTAMITON MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CROTAMITON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CROTAMITON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CROTAMITON MARKET SIZE, BY ITCH SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CROTAMITON MARKET SIZE, BY SYMPTOM ALLEVIATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CROTAMITON MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CROTAMITON MARKET SIZE, BY ECZEMA MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CROTAMITON MARKET SIZE, BY PSORIASIS CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CROTAMITON MARKET SIZE, BY INSECT BITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CROTAMITON MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CROTAMITON MARKET SIZE, BY SWELLING REDUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CROTAMITON MARKET SIZE, BY CONTAGION CONTROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CROTAMITON MARKET SIZE, BY SYMPTOM SUPPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CROTAMITON MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CROTAMITON MARKET SIZE, BY MEDICATED CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CROTAMITON MARKET SIZE, BY REGULAR CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CROTAMITON MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CROTAMITON MARKET SIZE, BY COOLING GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CROTAMITON MARKET SIZE, BY REGULAR GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CROTAMITON MARKET SIZE, BY LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CROTAMITON MARKET SIZE, BY DRY SKIN LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CROTAMITON MARKET SIZE, BY OILY SKIN LOTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CROTAMITON MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CROTAMITON MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CROTAMITON MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CROTAMITON MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CROTAMITON MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CROTAMITON MARKET SIZE, BY SELF-PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CROTAMITON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CROTAMITON MARKET SIZE, BY INPATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CROTAMITON MARKET SIZE, BY OUTPATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CROTAMITON MARKET SIZE, BY BULK ORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CROTAMITON MARKET SIZE, BY DIRECT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CROTAMITON MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CROTAMITON MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CROTAMITON MARKET SIZE, BY CHAIN STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CROTAMITON MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CROTAMITON MARKET SIZE, BY FIRST-LINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CROTAMITON MARKET SIZE, BY PREVENTIVE MEASURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CROTAMITON MARKET SIZE, BY LONG-TERM USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CROTAMITON MARKET SIZE, BY PERIODIC APPLICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CROTAMITON MARKET SIZE, BY POST-TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CROTAMITON MARKET SIZE, BY COMPLIMENTARY CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CROTAMITON MARKET SIZE, BY RECOVERY REGIMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CROTAMITON MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CROTAMITON MARKET SIZE, BY AGED 18-34, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CROTAMITON MARKET SIZE, BY AGED 35-50, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CROTAMITON MARKET SIZE, BY AGED 51 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CROTAMITON MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL CROTAMITON MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL CROTAMITON MARKET SIZE, BY SCHOOL-AGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL CROTAMITON MARKET SIZE, BY TODDLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL CROTAMITON MARKET SIZE, BY AGED 60-75, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL CROTAMITON MARKET SIZE, BY AGED 76 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS CROTAMITON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 166. CANADA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. CANADA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 168. CANADA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 169. CANADA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 170. CANADA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 171. CANADA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 172. CANADA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 173. CANADA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 174. CANADA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 175. CANADA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. CANADA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. CANADA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 178. CANADA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. CANADA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. CANADA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 181. CANADA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. CANADA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 183. CANADA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 184. CANADA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. CANADA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 186. CANADA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 187. CANADA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 188. CANADA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 189. CANADA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 190. CANADA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 191. MEXICO CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. MEXICO CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 193. MEXICO CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 194. MEXICO CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 196. MEXICO CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 197. MEXICO CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 198. MEXICO CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 199. MEXICO CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 200. MEXICO CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. MEXICO CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 203. MEXICO CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 204. MEXICO CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. MEXICO CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 206. MEXICO CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 207. MEXICO CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 208. MEXICO CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 209. MEXICO CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. MEXICO CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 211. MEXICO CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 212. MEXICO CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 213. MEXICO CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 214. MEXICO CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 215. MEXICO CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES CROTAMITON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CROTAMITON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 292. AUSTRALIA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 293. CHINA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 294. CHINA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 295. CHINA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 296. CHINA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 297. CHINA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 298. CHINA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 299. CHINA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 300. CHINA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 301. CHINA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 302. CHINA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. CHINA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 304. CHINA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 305. CHINA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 306. CHINA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. CHINA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 308. CHINA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 309. CHINA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 310. CHINA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 311. CHINA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 312. CHINA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 313. CHINA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 314. CHINA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 315. CHINA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 316. CHINA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 317. CHINA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 318. INDIA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. INDIA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 320. INDIA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 321. INDIA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 322. INDIA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 323. INDIA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 324. INDIA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 325. INDIA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 326. INDIA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 327. INDIA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 328. INDIA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 329. INDIA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 330. INDIA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 331. INDIA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 332. INDIA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 333. INDIA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 334. INDIA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 335. INDIA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 336. INDIA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 337. INDIA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 338. INDIA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 339. INDIA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 340. INDIA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 341. INDIA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 342. INDIA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 343. INDONESIA CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 344. INDONESIA CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 345. INDONESIA CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 346. INDONESIA CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 347. INDONESIA CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 348. INDONESIA CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 349. INDONESIA CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 350. INDONESIA CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 351. INDONESIA CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 352. INDONESIA CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 353. INDONESIA CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 354. INDONESIA CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 355. INDONESIA CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 356. INDONESIA CROTAMITON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 357. INDONESIA CROTAMITON MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 358. INDONESIA CROTAMITON MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 359. INDONESIA CROTAMITON MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 360. INDONESIA CROTAMITON MARKET SIZE, BY TREATMENT PHASE, 2018-2030 (USD MILLION)
TABLE 361. INDONESIA CROTAMITON MARKET SIZE, BY INITIAL TREATMENT, 2018-2030 (USD MILLION)
TABLE 362. INDONESIA CROTAMITON MARKET SIZE, BY MAINTENANCE THERAPY, 2018-2030 (USD MILLION)
TABLE 363. INDONESIA CROTAMITON MARKET SIZE, BY POST-TREATMENT, 2018-2030 (USD MILLION)
TABLE 364. INDONESIA CROTAMITON MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 365. INDONESIA CROTAMITON MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 366. INDONESIA CROTAMITON MARKET SIZE, BY CHILDREN, 2018-2030 (USD MILLION)
TABLE 367. INDONESIA CROTAMITON MARKET SIZE, BY GERIATRIC POPULATION, 2018-2030 (USD MILLION)
TABLE 368. JAPAN CROTAMITON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 369. JAPAN CROTAMITON MARKET SIZE, BY ALLERGY RELIEF, 2018-2030 (USD MILLION)
TABLE 370. JAPAN CROTAMITON MARKET SIZE, BY DERMATOLOGY, 2018-2030 (USD MILLION)
TABLE 371. JAPAN CROTAMITON MARKET SIZE, BY INSECT BITES, 2018-2030 (USD MILLION)
TABLE 372. JAPAN CROTAMITON MARKET SIZE, BY SCABIES TREATMENT, 2018-2030 (USD MILLION)
TABLE 373. JAPAN CROTAMITON MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 374. JAPAN CROTAMITON MARKET SIZE, BY CREAM, 2018-2030 (USD MILLION)
TABLE 375. JAPAN CROTAMITON MARKET SIZE, BY GEL, 2018-2030 (USD MILLION)
TABLE 376. JAPAN CROTAMITON MARKET SIZE, BY LOTION, 2018-2030 (USD MILLION)
TABLE 377. JAPAN CROTAMITON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 378. JAPAN CROTAMITON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 379. JAPAN CROTAMITON MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 380. JAPAN CROTAMITON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 381. JAPAN CROTAMITON MARKET SIZE, BY DISTRI

Companies Mentioned

The companies profiled in this Crotamiton market report include:
  • Galderma S.A.
  • Sandoz International GmbH
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Laboratoires Gilbert
  • Riemser Pharma GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages193
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 141.64 Million
Forecasted Market Value ( USD ) by 2030 $ 176.43 Million
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Crotamiton (CAS 483-63-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Crotamiton (CAS 483-63-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Antiseptics Market by Product Type, Form, Application, End User, Distribution Channel, Packaging Type - Global Forecast to 2030 - Product Image

Antiseptics Market by Product Type, Form, Application, End User, Distribution Channel, Packaging Type - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Sepsis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Glycopeptide, Aminoglycosides), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Sepsis Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Glycopeptide, Aminoglycosides), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 153 Pages
  • Global
From
Packaging Films Market by Application (Food, Beverage, Pharmaceutical & Healthcare, Personal Care & Cosmetics), Film(PE, BOPP, BOPET, CPP, PVC, PA, EVOH, Cellulose), Type (Pouches, Bags, Films & Wraps, Rollstock), Region - Global Forecast to 2033 - Product Image

Packaging Films Market by Application (Food, Beverage, Pharmaceutical & Healthcare, Personal Care & Cosmetics), Film(PE, BOPP, BOPET, CPP, PVC, PA, EVOH, Cellulose), Type (Pouches, Bags, Films & Wraps, Rollstock), Region - Global Forecast to 2033

  • Report
  • 420 Pages
  • Global
From

About the Crotamiton Market

Crotamiton is a topical antipruritic and scabicidal drug used to treat skin conditions caused by infectious diseases. It is used to treat scabies, a contagious skin infestation caused by the mite Sarcoptes scabiei, as well as other skin conditions such as pruritus, dermatitis, and eczema. It is available in both cream and lotion forms and is typically applied to the affected area two to three times a day. Crotamiton is a safe and effective treatment for scabies and other skin conditions caused by infectious diseases. It is generally well tolerated and has few side effects. It is also relatively inexpensive, making it an attractive option for those who cannot afford more expensive treatments. Some companies that produce and market crotamiton include GlaxoSmithKline, Merck, and Bayer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.